LYPLA1 was found to be associated with poor prognosis in lung adenocarcinoma [25], while POLR2K was identified as one of the top 10 cancer immunotherapy proteins related to breast cancer by machine-learning predictions [26]. Here, LYPLA1 is linked to breast carcinoma.